Tag Archives: Memorial Sloan Kettering Cancer Center

Health Care

Memorial Sloan Kettering Cancer Center (MSK)’s Groundbreaking Advances in Cancer Treatment

MSK presents research that could reshape what is possible for patients with four major cancers

Landmark findings in pancreatic, lung, liver, and prostate cancer mark one of MSK’s most significant contributions to cancer research in recent years

ABU DHABI, DUBAI, RIYADH, DOHA, 7th July 2026. Memorial Sloan Kettering Cancer Center (MSK) has announced significant research advances across four cancers where patients have long faced limited options.

The findings, presented at the American Society of Clinical Oncology Annual Meeting, the world’s largest gathering of cancer specialists, include the first drug to successfully target the genetic fault driving nine in ten pancreatic cancers, a major step forward in preventing lung cancer recurrence, and new options for patients with advanced liver and prostate cancer. For patients across the Gulf region, where these cancers carry a particularly high burden, the advances have direct relevance.

Continue reading Memorial Sloan Kettering Cancer Center (MSK)’s Groundbreaking Advances in Cancer Treatment →
Health Care

Ovarian Cancer Awareness: Early Detection in Gulf Women

Young women, late diagnoses: Memorial Sloan Kettering Cancer Center urges greater awareness of ovarian cancer across the Gulf

New research shows how inherited genetics vary across populations and can influence which cancers a woman develops and how they respond to treatment

ABU DHABI, DUBAI, RIYADH, DOHA, 8 May 2026. On World Ovarian Cancer Day, Memorial Sloan Kettering Cancer Center (MSK), one of the world’s leading cancer centers, is urging women and families across the Gulf region to prioritize early evaluation for ovarian cancer. In the Gulf, women tend to be diagnosed with cancer at a younger age than in Western countries, with peak female cancer incidence falling between 40 and 60 years, compared to a global median ovarian cancer diagnosis age of 63.[1] For a disease where catching it early can mean the difference between a strong chance of survival and a slim one, that earlier window matters enormously.

Ovarian cancer is one of the hardest cancers to detect early. Its symptoms, including bloating, pelvic discomfort, and changes in appetite, are easily attributed to other causes. Globally, around two-thirds of cases are diagnosed at stage III or IV, when the disease has already spread. As specialist gynaecologic oncology services continue to develop across the Gulf, access to internationally recognised centres remains an important option for patients with complex or advanced disease.

“When ovarian cancer is caught early, survival rates are dramatically higher,” said Nadeem R. Abu-Rustum, Chief of the Gynecologic Service at MSK. “The challenge is building the awareness and access that make early detection possible, and that starts with women feeling confident to raise their concerns with a doctor.”

New research shows how inherited genetics shape tumor genomes

MSK oncologist Dr. Jian Carrot-Zhang

Continue reading Ovarian Cancer Awareness: Early Detection in Gulf Women →
Health Care

Memorial Sloan Kettering Cancer Center Showcases Pioneering Cancer Research for World Cancer Research Day

From uncovering why young adults face rising cancer rates to pioneering vaccines and new therapies, MSK’s latest research is shaping the future of cancer care in the Middle East and worldwide.

DOHA, DUBAI, RIYADH. September 24, 2025. On World Cancer Research Day, Memorial Sloan Kettering Cancer Center (MSK) highlights pioneering research that is improving treatment options, expanding access to precision care, and offering hope to patients across the Middle East.

Continue reading Memorial Sloan Kettering Cancer Center Showcases Pioneering Cancer Research for World Cancer Research Day →
Health Care

Memorial Sloan Kettering Cancer Center Ranked as the Best Cancer Center in the Northeast U.S. and New York

Memorial Sloan Kettering Cancer Center Ranked as the Best Cancer Center in the Northeast U.S. and New York, Second in the Nation, and First for Urology Care by U.S. News & World Report

Greeting a patient at Memorial Sloan Kettering’s Bobst International Center

Middle East, 11August 2025:Memorial Sloan Kettering Cancer Center (MSK), a global leader in cancer care and research, has been recognized as the best cancer center in the Northeast United States and New York, the number two hospital for cancer care in the United States, and the number one hospital nationally for urology care by U.S. News & World Report in its annual Best Hospitals listing. MSK has ranked as one of the top two cancer hospitals in the U.S. and the best cancer center in New York since these rankings were established more than 35 years ago., underscoring its longstanding commitment to excellence and innovation in cancer treatment.

Continue reading Memorial Sloan Kettering Cancer Center Ranked as the Best Cancer Center in the Northeast U.S. and New York →